AI assistant
Sending…
Tarsus Pharmaceuticals, Inc. — Director's Dealing 2021
Aug 13, 2021
31511_dirs_2021-08-12_a58438a2-6d3b-4961-8899-fdf8316606d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Tarsus Pharmaceuticals, Inc. (TARS)
CIK: 0001819790
Period of Report: 2021-08-11
Reporting Person: Crane Rosemary A (Director)
More from Tarsus Pharmaceuticals, Inc.
Report Publication Announcement
2026
May 6
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Mar 19